DexCom (DXCM) Misses Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $79.37 -1.11%
Revenue Growth %: +9.9%
Financial Fact:
Net loss: -18.8M
Today's EPS Names:
SICP, MNSB, CFFI, More
Revenue Growth %: +9.9%
Financial Fact:
Net loss: -18.8M
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.24), $0.12 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $137.3 million versus the consensus estimate of $132.59 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Meta Platforms Inc. (META) PT Raised to $850 at Bernstein SocGen Group
- SanDisk stock falls amid memory sector retreat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
